Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. United Health Products, Inc.
WARNING LETTER
•United Health Products, Inc.•October 4, 2024

United Health Products, Inc. – FDA Warning Letter, Oct 4, 2024

Record Details

On March 24, 2025, the FDA issued a Warning Letter to United Health Products, Inc. following an inspection from September 23 to October 4, 2024. The inspection, part of the Bioresearch Monitoring (BIMO) Program, assessed compliance for the "Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting" clinical study for CelluSTAT Absorbable Hemostat, a Class III device.

The FDA identified serious violations of 21 CFR Part 812 (Investigational Device Exemptions) and 21 CFR Part 50 (Protection of Human Subjects). Key violations include:

1. **Failure to Submit and Obtain IDE Approval:** United Health Products, Inc. conducted study UHP001, a significant risk device investigation, without submitting an IDE application or obtaining FDA approval. The company misrepresented FDA's risk determination to the IRB by modifying official FDA correspondence. 2. **Failure to Ensure Proper Monitoring:** The company lacked an effective and implemented Clinical Monitoring Plan (CMP) and failed to maintain adequate documentation for site initiation visits (SIVs) and interim monitoring visits. 3. **Failure to Secure Clinical Investigator Compliance:** The sponsor failed to ensure investigators adhered to the investigational plan, leading to enrollment of subjects who met exclusion criteria (e.g., thrombocytopenia) and failure to obtain

Company
United Health Products, Inc.
Inspection date
October 4, 2024
Product type
Devices
Office
Center for Devices and Radiological Health
Person
  • Soma Kalb (Division Director)
View Company Profile

ID · 28f99c32-fac1-4ec4-9971-59be859070ca

Violation Codes10
21 U.S.C. 321(h)(1)21 CFR 81221 CFR 5021 U.S.C. 360j(g)21 CFR 812.20(a)(1)21 CFR 812.20(a)(2)21 CFR 878.449021 CFR 812.3(m)21 CFR 812.4021 CFR 812.46(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore United Health Products, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.